NYSE:EVH | Free Cash Flow | Evolent Health, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2013-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$984,000.00
2025-12-31$48.8M
2025-03-31$4.57M
2024-12-31-$26.23M
2024-03-31$4.91M
2023-12-31$89.38M
2023-03-31-$7.97M
2022-12-31$35.7M
2022-03-31-$57.44M
2021-12-31$66.66M
2021-03-31-$48.16M
2020-12-31-$12.85M
2020-03-31-$20.54M
2019-12-31$13.19M$9.16M$4.03M
2019-03-31-$25.71M$9.46M-$35.17M
2018-12-31-$24.97M$10.43M-$35.4M
2018-03-31-$24.71M$9.55M-$34.26M
2017-12-31$6.04M$6.5M-$464,000.00
2017-03-31-$34.77M$5.98M-$40.74M
2016-12-31-$21.51M$4.41M-$25.92M
2016-03-31-$20.8M$3.35M-$24.16M
2015-12-31-$6.31M$2.61M-$8.92M
2015-03-31$0.00$0.00$0.00
2014-12-31$0.00$0.00$0.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31$38.84M
2024-12-31$18.77M
2023-12-31$142.58M
2022-12-31-$11.55M
2021-12-31$38.75M
2020-12-31-$16.23M
2019-12-31-$42.65M$35.53M-$78.18M
2018-12-31-$20.65M$39.55M-$60.2M
2017-12-31-$27.96M$27.85M-$55.81M
2016-12-31-$35.51M$15.53M-$51.04M
2015-12-31-$18.47M$6.52M-$24.98M-7.51%
2014-12-31$0.00$0.00$0.00
2013-12-31-$13.63M$10.44M-$24.07M-120.20%